SHAREHOLDER ALERT: Investigation of Teladoc Health (TDOC) Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - April 28, 2022) - Holzer & Holzer, LLC is investigating whether Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC) complied with federal securities laws. On April 27, 2022, Teladoc reported first quarter financial results for the quarter ended March 31, 2022. The Company announced it was revising and lowering its 2022 outlook due to a "lower-than-expected yield" on the Company's marketing spend and a net loss per share of $41.58, which was attributed to a "non-cash goodwill impairment charge of $6.6 billion." Following this announcement, the Company's stock price dropped.
If you purchased Teladoc stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at email@example.com or Joshua Karr, Esq. at firstname.lastname@example.org, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com to discuss your legal rights.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/122066